Virtu Financial LLC Paratek Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$1.37 - $2.54 $24,923 - $46,207	18,192 New	18,192 $46,000
Q2 2021 Sep 17, 2021	SELL	$6.81 - $10.93 $69,421 - $111,420	-10,194 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$6.14 - $8.31 $13,618 - $18,431	-2,218 Reduced 17.87%	10,194 $72,000
Q4 2020 Feb 24, 2021	SELL	$4.58 - $7.14 $75,409 - $117,560	-16,465 Reduced 57.02%	12,412 $78,000
Q3 2020 Dec 11, 2020	BUY	$4.19 - $6.69 $120,994 - $193,187	28,877 New	28,877 $156,000
Q2 2020 Aug 07, 2020	SELL	$2.97 - $5.22 $76,254 - $134,023	-25,675 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$2.93 - $4.5 $75,227 - $115,537	25,675 New	25,675 $103,000
Q1 2019 Apr 12, 2019	SELL	$5.36 - $7.24 $186,983 - $252,567	-34,885 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$4.8 - $11.6 $167,448 - $404,666	34,885 New	34,885 $179,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.